Why the study?
Does ischemic preconditioning improve myocardial function and diminish infarction in ischemic heart disease?
Population
Experimental animals and humans
Design
Review
Authors
Loading...
Does not support clinical adoption of ischemic preconditioning; leaves open PKC pathway translation to therapies in ischemic heart disease.
Does ischemic preconditioning improve myocardial function and diminish infarction in ischemic heart disease?
Understanding the mechanisms of ischemic preconditioning, particularly the role of PKC, may lead to novel routine treatments to salvage ischemic myocardium in patients with ischemic heart disease.
Cohen et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: